| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/30/2009 | CA2703793A1 Oxadiazolidinedione compound |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703653A1 Pyridine and pyrazine derivatives -083 |
| 04/30/2009 | CA2703593A1 4,4-disubstituted piperidines |
| 04/30/2009 | CA2703479A1 Therapeutic substituted lactams |
| 04/30/2009 | CA2703465A1 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist |
| 04/30/2009 | CA2703106A1 Azolecarboxamide derivatives as trka inhibitors |
| 04/30/2009 | CA2702976A1 2-aminooxazole derivatives as trpv1 antagonists useful for treating pain |
| 04/30/2009 | CA2702974A1 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | CA2702772A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | CA2702126A1 Heterocycle amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/29/2009 | EP2053042A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP2051977A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
| 04/29/2009 | EP1828127A4 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1651592B1 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 04/29/2009 | EP1542994B1 Novel oxazole compounds as transforming growth factor (tgf) inhibitor |
| 04/29/2009 | EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421264A Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101421262A Compounds and compositions as protein kinase inhibitors |
| 04/29/2009 | CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/29/2009 | CN100482660C Flouroquinolone-oxazolidone derivative, composition, preparation method and application thereof |
| 04/29/2009 | CN100482659C Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 04/29/2009 | CN100482649C Organic compounds |
| 04/29/2009 | CN100482648C New uracils having a herbicidal activity |
| 04/29/2009 | CN100482647C Pyrazole derivatives useful as COX-I inhibitors |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524954 Reacting 3-fluoro-4-morpholinyl aniline derivative with epichlorohydrin; converting chloromethyl oxazolidinone to aminomethyl oxazolidinone; carbonylation ; reacting with potassium phthalimide, hydrazine hydrate, and acetic anhydride; cyclization, carbamylation |
| 04/28/2009 | US7524882 PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | US7524837 Benzotriazapinone salts and methods for using same |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052063A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 04/23/2009 | WO2009052062A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051956A2 Pyrazole-substituted isoxazoline insecticides |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050999A1 Indolium compound and optical recording material using the compound |
| 04/23/2009 | WO2009050523A1 Azetidinyl g-protein coupled receptor agonists |
| 04/23/2009 | WO2009050258A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |
| 04/23/2009 | WO2009050253A1 Trisubstituted piperidines |
| 04/23/2009 | WO2009050232A1 Cgrp antagonists |
| 04/23/2009 | WO2009050204A1 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 04/23/2009 | WO2009050201A2 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 04/23/2009 | WO2009050200A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators |
| 04/23/2009 | WO2009050197A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 04/23/2009 | WO2009049846A1 Insecticidal compounds |
| 04/23/2009 | WO2009049844A1 Insecticidal compounds |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009017822A3 Pi3 kinase modulators and methods of use |
| 04/23/2009 | WO2009007751A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009007748A3 Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |
| 04/23/2009 | WO2008152094A3 Substituted acetamides as modulators of the ep2 receptor |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | US20090105488 Triptycene derivatives and their application |
| 04/23/2009 | US20090105484 Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agents |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105299 c-MET MODULATORS AND METHODS OF USE |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105275 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105273 Diacylglycerol Acyltransferase Inhibitors |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105253 Triazole Derivative and Use Thereof |
| 04/23/2009 | US20090105252 Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease |
| 04/23/2009 | US20090105251 Renin inhibitors |
| 04/23/2009 | US20090105249 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/23/2009 | US20090105247 tert-butyl 4-((4-(3-ethynylphenylamino)quinazolin-6-ylcarbamoyl)methylene)piperidine-1-carboxylate, used for treating or preventing physiological disorder caused by epidermal growth factor receptor (EGFR) or ERBB/Her-2 gene overexpression in mammals; anticarcinogenic agents |
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105239 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 04/23/2009 | US20090105234 EP4 Receptor Agonist, Compositions and Methods Thereof |
| 04/23/2009 | US20090105233 Serine-threonine protein kinase and parp modulators |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105225 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists |
| 04/23/2009 | US20090105217 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105214 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| 04/23/2009 | US20090105211 Inhibitors of hedgehog pathway |
| 04/23/2009 | US20090104677 Heteroaromatic Selective Inhibitors of Neuronal Nitric Oxide Synthase |
| 04/23/2009 | CA2702834A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 04/23/2009 | CA2702745A1 Trisubstituted piperidines |
| 04/23/2009 | CA2702563A1 Cgrp antagonists |
| 04/23/2009 | CA2702307A1 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them |